AstraZeneca buys cell therapy firm EsoBiotec for $1bn
British pharmaceutical giant AstraZeneca on Monday announced an agreement to buy Belgian cell therapy firm EsoBiotec for up to $1 billion, expanding its treatments for cancer.
Mar 17, 2025
0
0